Revvity Inc (FRA:PKN)
€ 114.9 +9.05 (+8.55%) Market Cap: 13.55 Bil Enterprise Value: 15.56 Bil PE Ratio: 65.12 PB Ratio: 2.12 GF Score: 76/100

Revvity, Inc. at Robert W Baird Global Healthcare Conference Transcript

Sep 15, 2026 / 10:59 AM GMT
Release Date Price: €114.9 (+8.55%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RVTY.N - Revvity, Inc.
Revvity, Inc. at Robert W Baird Global Healthcare Conference
Sep 15, 2026 / NTS GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Perfect.

All right, great. Good morning, everyone. My name is Robbie Bamberger, Senior Research Analyst covering life sciences and diagnostic. I'm very pleased to be joined this morning by Steve Willoughby, Senior VP of Investor Relations at Revity. Steve, thanks for making the trip. I guess before we get into segment specifics on the company, would you just mind giving us a quick breakdown, snapshot of the company coming off of Q2 earnings print? What went right in the quarter and anything you'd like to just point out to investors about the quarter in general?

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot